/Investor DB

Angelini Ventures — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Avation Medicalavation.comin𝕏Feb 2024 · $22M

Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.

Digital HealthHealthtechMedical DevicesValencia, US

Manish Vaishya, PhD(Chief Executive Officer, Co-Founder & Board Member)Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)

BoardThomas Shehab, MD(Director)

Co-investorsArboretum VenturesAsahi Kasei Corporate Venture CapitalAvestria VenturesShangBay Capital LLC

Noctrix Healthnoctrixhealth.comJan 2024 · $40M

Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.

Digital HealthMedical DevicesWellness & FitnessPleasanton, US

Shri Raghunathan(Founder)inShriram Raghunathan(Executive Officer, Director)

BoardChau Khuong(Director)inAllan May(Director)Mudit Jain(Director)inTracy Pappas(Director)in

Co-investorsBlue Venture FundsJoyance PartnersOrbiMedTreo Ventures, LlcZühlke VenturesBridge Bank+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.